期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 113, 期 26, 页码 E3745-E3754出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1601368113
关键词
carbapenemase; antibiotic resistance; inhibitors; bisthiazolidines; metallo-beta-lactamase
资金
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI100560]
- Cleveland Department of Veterans Affairs [1I01BX001974]
- Biomedical Laboratory Research & Development Service of the VA Office of Research and Development
- Geriatric Research Education and Clinical Center VISN [10]
- UK Medical Research Council UK-Canada [G1100135]
- [R01AI063517]
- [R01AI072219]
- MRC [G1100135] Funding Source: UKRI
- Medical Research Council [G1100135] Funding Source: researchfish
Metallo-beta-lactamases (MBLs) hydrolyze almost all beta-lactam antibiotics and are unaffected by clinically available beta-lactamase inhibitors (beta LIs). Active-site architecture divides MBLs into three classes (B1, B2, and B3), complicating development of beta LIs effective against all enzymes. Bisthiazolidines (BTZs) are carboxylate-containing, bicyclic compounds, considered as penicillin analogs with an additional free thiol. Here, we show both L- and D-BTZ enantiomers are micromolar competitive beta LIs of all MBL classes in vitro, with K(i)s of 6-15 mu M or 36-84 mu M for subclass B1 MBLs (IMP-1 and BcII, respectively), and 10-12 mu M for the B3 enzyme L1. Against the B2 MBL Sfh-I, the L-BTZ enantiomers exhibit 100-fold lower K(i)s (0.26-0.36 mu M) than D-BTZs (26-29 mu M). Importantly, cell-based time-kill assays show BTZs restore beta-lactam susceptibility of Escherichia coli-producing MBLs (IMP-1, Sfh-1, BcII, and GOB-18) and, significantly, an extensively drug-resistant Stenotrophomonas maltophilia clinical isolate expressing L1. BTZs therefore inhibit the full range of MBLs and potentiate beta-lactam activity against producer pathogens. X-ray crystal structures reveal insights into diverse BTZ binding modes, varying with orientation of the carboxylate and thiol moieties. BTZs bind the di-zinc centers of B1 (IMP-1; BcII) and B3 (L1) MBLs via the free thiol, but orient differently depending upon stereochemistry. In contrast, the L-BTZ carboxylate dominates interactions with the monozinc B2 MBL Sfh-I, with the thiol uninvolved. D-BTZ complexes most closely resemble beta-lactam binding to B1 MBLs, but feature an unprecedented disruption of the D120-zinc interaction. Cross-class MBL inhibition therefore arises from the unexpected versatility of BTZ binding.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据